Skip to main content
OpenTrials
Completed

NCT Number: NCT03630549

Village-based vs Clinic-based ART Care - a Cluster Randomized Controlled Trial in Lesotho

This cluster-randomized trial tests a differentiated care model for HIV-positive individuals not on ART during a home-based HIV testing campaign in rural Lesotho, Southern Africa. In intervention clusters, patients are offered a differentiated ART delivery package with two features. Firstly, drug-refill and follow-up are provided by village health workers (VHW), reducing clinic visits to twice a year for laboratory assessment. Secondly, participants have the option of receiving individually tailored adherence reminders and viral load result notifications via SMS.

Completed

Looking for future studies?

Notify Me

Key information

Age range

10 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

District of Butha-Buthe, Butha-Buthe, Lesotho

Loading trial locations.

About this study

The VIBRA trial is a cluster randomized controlled, open-label, superiority trial in a resource-limited setting. The trial is linked to a another trial, the HOSENG (HOme-based SElf-testiNG) trial, that is described elsewhere (NCT03598686). Together, they consitute the GET ON (GETing tOwards Ninety) research project. The HOSENG study, with its home-based HIV testing campaign, provides the recruitment platform for the VIBRA study. The reasons for this interlinked design are: a) potential study participants for VIBRA trial (HIV-positive individuals not on ART) are to be recruited during a home-based HIV testing campaign and hence, it allows us to assess the entire HIV care cascade in one larger project, and b) both trials rely on interventions involving VHWs, who need to be randomized and specifically trained. Therefore, it is efficient and feasible to run both trials parallel and randomize at one time point only. The rational for a cluster randomized design is the reliance of the trial on the VHWs and, thus, the high risk of cross-contamination between the study arms if randomization would be done at individual level.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

for clusters:

  • the cluster is clearly confined to the catchment area of one of the study clinics
  • the cluster has at least one registered VHW who is willing to participate and fulfills the following criteria:
  • is at least 18 years of age
  • has adequate reading and writing skills
  • successfully passes the training assessment
  • village authority (village chief) is willing to participate in trial

Exclusion criteria

for clusters:

  • Village authority (=village chief) opposed to trial participation (verbal assent)
  • Village health worker opposed to trial participation or not fulfilling the minimum requirements mentioned above

Inclusion criteria

for individuals:

  • Individual is a household member of the visited households of the respective clusters
  • Individual is confirmed HIV-positive
  • Individual has never taken ART (ART-naïve) or has stopped ART more than 30 days prior (ART-defaulters)
  • Individual is ≥10 years old and has a body weight of ≥35kg
  • Individual is not in care for high blood pressure or diabetes (high blood sugar)
  • HIV-positive individual wishes to get care outside the study districts

Exclusion criteria

individuals:

  • The household member is absent at the time of the campaign
  • HIV-positive individual is taking ART or stopped less than 30 days ago
  • HIV-positive individual is physically, mentally, or emotionally not able to participate in the study, in the opinion of the investigators or study staff
  • HIV-positive individual is in care for high blood pressure (hypertension) or high blood sugar (diabetes) - proof of documentation or medication needed
  • HIV-positive individual wishes to get care outside the study districts

Treatment and study plan

Standard of care

Other

Clinic-based HIV care

Village-based ART refill

Other

Option to get ART refill and care by the village health worker

Other names: VIBRA

Primary outcomes

  1. 12-months viral suppression

    Time frame: 12 months (range: 10 - 15 months) after enrolment.

    Viral suppression at 12 months, defined as the proportion of all participants with a VL <20 copies/mL

  2. 12-months viral suppression (<400copies/mL)

    Time frame: 12 months (range: 10 - 15 months) after enrolment.

    Viral suppression at 12 months, defined as the proportion of all participants with a VL <400 copies/mL

Secondary outcomes

  1. 6-months viral suppression

    Time frame: 6 months (range 5 - 8 months) after enrolment

    Viral suppression at 6 months, defined as the proportion of all participants with a VL <20 copies/mL

  2. Alternative viral suppression at 12 months

    Time frame: 12 months (range 10 - 15 months) after enrolment.

    The proportion of all participants with a VL <1000 copies/mL

  3. Alternative viral suppression at 6 months

    Time frame: 6 months (range 5 - 8 months) after enrolment

    The proportion of all participants with a VL <1000 copies/mL

  4. Sustained viral suppression

    Time frame: 12 months (range 5 - 15 months) after enrollment

    The proportion of all participants with a VL <20 copies/mL at 6 (range 5 - 8 months) as well as at 12 months (range 10 - 15 months) after enrolment

  5. 1-month linkage to care

    Time frame: 30 days after enrollment

    Linkage to care within 1 month, defined as the proportion of all participants attending the first clinic- or VHW-based ART visit at least once within 1 month after enrolment

  6. 3-months linkage to care

    Time frame: 90 days

    Linkage to care within 3 months, defined as the proportion of all participants attending the first clinic- or VHW-based ART visit at least once within 3 months after enrolment

  7. 6-months retention in care

    Time frame: 5-8 months after enrollment

    The proportion of all participants active in care at a health facility or at the VHW 6 months (range 5 - 8 months) after enrollment

  8. 12-months retention in care

    Time frame: 12 months (range 10 - 15 months) after enrolment

    the proportion of all participants active in care at a health facility or at the VHW

  9. All-cause mortality at 12 months

    Time frame: 12 months (range 10 - 15 months) after enrolment

    The proportion of all participants who died

  10. Loss to follow-up at 12 months

    Time frame: 12 months (range 10 - 15 months) after enrollment

    The proportion of all participants lost to follow-up

  11. Confirmed transfer out at 12 months

    Time frame: 12 months (range 10 - 15 months) after enrolment

    The proportion of all participants who transferred out to any other health facility (than the one initially registered) outside the study districts with a proof of transfer (documented proof of follow-up visit or laboratory test)

  12. Unconfirmed transfer out at 12 months

    Time frame: 12 months (range 10 - 15 months) after enrolment

    The proportion of all participants who transferred out to any other health facility (than the one initially registered) outside the study districts without a proof of transfer at 12 months (range 10 - 15 months) after enrolment

Sponsors and collaborators

Lead sponsor

Niklaus Labhardt

Other

Collaborators

  • Ministry of Health, Lesotho
  • SolidarMed
  • University Hospital, Basel, Switzerland
  • University of Basel

Registry information

Official study title

Village-based Refill of ART After Same-day ART Start vs Clinic-based ART Refill for HIV-positive Individuals Not on ART During Home-based HIV Testing (Part B of GET ON Research Project)

Acronym: VIBRA

Important dates

Study start
2018
Primary completion
2020
Study completion
2020
First posted
Aug 15, 2018
Registry last updated
Apr 1, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.